Capsaicin protects cardiomyocytes against lipopolysaccharide-induced damage via 14-3-3γ-mediated autophagy augmentation

被引:31
|
作者
Qiao, Yang [1 ]
Wang, Liang [2 ]
Hu, Tianhong [3 ]
Yin, Dong [4 ]
He, Huan [3 ]
He, Ming [1 ]
机构
[1] Nanchang Univ, Inst Cardiovasc Dis, Jiangxi Acad Clin Med Sci, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
[2] Nanchang Univ, Dept Rehabil, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
[3] Nanchang Univ, Sch Pharmaceut Sci, Jiangxi Prov Key Lab Basic Pharmacol, Nanchang, Jiangxi, Peoples R China
[4] Nanchang Univ, Jiangxi Prov Key Lab Mol Med, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China
关键词
14-3-3γ Autophagy; Cardiac dysfunction; Capsaicin; lipopolysaccharide; Mitochondria; INDUCED CARDIAC DYSFUNCTION; MITOCHONDRIAL DYSFUNCTION; SEVERE SEPSIS; ANOXIA/REOXYGENATION INJURY; SEPTIC SHOCK; AMPK; ACTIVATION; SURVIVAL; GROWTH; DEATH;
D O I
10.3389/fphar.2021.659015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The myocardium is susceptible to lipopolysaccharide (LPS)-induced damage in sepsis, and cardiac dysfunction is a leading cause of mortality in patients with sepsis. The changes in cardiomyocyte autophagy in sepsis and the effects and mechanism of action of capsaicin (Cap) remain unclear. Methods and Results: The potential pathway of 14-3-3 gamma-dependent autophagy and the effects and mechanisms of Cap were studied in LPS-induced injury to primary cultured neonatal rat cardiomyocytes. The results showed that cardiomyocyte viability decreased, lactate dehydrogenase and creatine kinase activities increased, 14-3-3 gamma expression was downregulated, and autophagy was inhibited after LPS challenge. Cap pretreatment augmented autophagy by upregulating 14-3-3 gamma expression and activating AMP-activated protein kinase (AMPK) and unc-51 like autophagy-activating kinase 1 (ULK1), suppressing mammalian target of rapamycin (mTOR), alleviating cardiac dysfunction and improving the inflammation response, whereas pAD/14-3-3 gamma-shRNA nullified the above effects. Cap pretreatment also decreased the levels of IL-1 beta, TNF-alpha, IL-6, and IL-10; suppressed intracellular oxidative stress; reduced the intracellular/mitochondrial reactive oxygen species (ROS); balanced GSH/GSSG; increased GSH-Px, catalase, and SOD activities; and decreased MDA contents. It also increased ATP content, activated complex ? and complex stabilized the mitochondrial membrane potential, and decreased the mitochondrial permeability transition pore opening, thereby improving mitochondrial function. Conclusion: Pretreatment with Cap can regulate autophagy by upregulating 14-3-3 gamma expression, inhibiting oxidative stress and inflammation, maintaining mitochondrial function, and protecting cardiomyocytes against LPS-induced injury.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome
    Pei Jiang
    Yujin Guo
    Ruili Dang
    Mengqi Yang
    Dehua Liao
    Huande Li
    Zhen Sun
    Qingyan Feng
    Pengfei Xu
    Journal of Neuroinflammation, 14
  • [32] Ablation of Akt2 protects against lipopolysaccharide-induced cardiac dysfunction: Role of Ala ubiquitination E3 ligase TRAF6
    Zhang, Yingmei
    Xu, Xihui
    Ceylan-Isik, Ash I. F.
    Dong, Maolong
    Pei, Zhaohui
    Li, Yan
    Ren, Jun
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2014, 74 : 76 - 87
  • [33] 3-Dehydroandrographolide protects against lipopolysaccharide-induced inflammation through the cholinergic anti-inflammatory pathway
    Lu, Zibin
    Xie, Pei
    Zhang, Dongmei
    Sun, Pinghua
    Yang, Huayi
    Ye, Jiaxi
    Cao, Huihui
    Huo, Chuying
    Zhou, Hongling
    Chen, Yuyao
    Ye, Wencai
    Yu, Linzhong
    Liu, Junshan
    BIOCHEMICAL PHARMACOLOGY, 2018, 158 : 305 - 317
  • [34] Sphingosylphosphorylcholine protects cardiomyocytes against ischemic apoptosis via lipid raft/PTEN/Akt1/mTOR mediated autophagy
    Yue, Hong-Wei
    Liu, Jing
    Liu, Ping-Ping
    Li, Wen-Jing
    Chang, Fen
    Miao, Jun-Ying
    Zhao, Jing
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2015, 1851 (09): : 1186 - 1193
  • [35] Piceatannol Protects Brain Endothelial Cell Line (bEnd.3) against Lipopolysaccharide-Induced Inflammation and Oxidative Stress
    Zhou, Yan
    Khan, Haroon
    Hoi, Maggie Pui Man
    Cheang, Wai San
    MOLECULES, 2022, 27 (04):
  • [36] 4-Phenylbutyric acid protects against lipopolysaccharide-induced bone loss by modulating autophagy in osteoclasts
    Park, Hyun-Jung
    Son, Ho-Jung
    Sul, Ok-Joo
    Suh, Jae-Hee
    Choi, Hye-Seon
    BIOCHEMICAL PHARMACOLOGY, 2018, 151 : 9 - 17
  • [37] GSK-3β inhibition protects the rat heart from the lipopolysaccharide-induced inflammation injury via suppressing FOXO3A activity
    Li, Zhigang
    Zhu, Huifang
    Liu, Chang
    Wang, Yumei
    Wang, Duo
    Liu, Huan
    Cao, Wenze
    Hu, Yi
    Lin, Qin
    Tong, Chang
    Lu, Min
    Sachinidis, Agapios
    Li, Li
    Peng, Luying
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (11) : 7796 - 7809
  • [38] Coptisine protects cardiomyocyte against hypoxia/reoxygenation-induced damage via inhibition of autophagy
    Wang, Yahui
    Wang, Qiangli
    Zhang, Lu
    Ke, Zunli
    Zhao, Yuanyuan
    Wang, Dongshani
    Chen, Hui
    Jiang, Xi
    Gu, Ming
    Fan, Shengjie
    Huang, Cheng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 490 (02) : 231 - 238
  • [39] Dihydromyricetin protects against liver ischemia/reperfusion induced apoptosis via activation of FOXO3a-mediated autophagy
    Chen, Yongbiao
    Lv, Lizhi
    Pi, Huifeng
    Qin, Weijia
    Chen, Jianwei
    Guo, Dengfang
    Lin, Jianyu
    Chi, Xiaobing
    Jiang, Zhelong
    Yang, Hejun
    Jiang, Yi
    ONCOTARGET, 2016, 7 (47) : 76508 - 76522
  • [40] Dexmedetomidine Protects Against Lipopolysaccharide-Induced Acute Kidney Injury by Enhancing Autophagy Through Inhibition of the PI3K/AKT/mTOR Pathway
    Zhao, Yuan
    Feng, Xiujing
    Li, Bei
    Sha, Jichen
    Wang, Chaoran
    Yang, Tianyuan
    Cui, Hailin
    Fan, Honggang
    FRONTIERS IN PHARMACOLOGY, 2020, 11